Gamco Investors INC. ET AL increased its position in shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) by 25.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 40,000 shares of the medical device company’s stock after acquiring an additional 8,000 shares during the quarter. Gamco Investors INC. ET AL owned about 0.09% of K2M Group Holdings worth $848,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. Goldman Sachs Group Inc. raised its holdings in K2M Group Holdings by 82.3% during the 2nd quarter. Goldman Sachs Group Inc. now owns 211,585 shares of the medical device company’s stock worth $5,154,000 after buying an additional 95,548 shares during the period. Artemis Investment Management LLP raised its holdings in K2M Group Holdings by 255.4% during the 2nd quarter. Artemis Investment Management LLP now owns 316,703 shares of the medical device company’s stock worth $7,716,000 after buying an additional 227,582 shares during the period. Schroder Investment Management Group raised its holdings in K2M Group Holdings by 1.6% during the 2nd quarter. Schroder Investment Management Group now owns 1,560,340 shares of the medical device company’s stock worth $37,401,000 after buying an additional 24,671 shares during the period. Ameriprise Financial Inc. acquired a new stake in K2M Group Holdings during the 2nd quarter worth approximately $1,664,000. Finally, Credit Suisse AG raised its holdings in K2M Group Holdings by 9.8% during the 1st quarter. Credit Suisse AG now owns 212,672 shares of the medical device company’s stock worth $4,360,000 after buying an additional 18,931 shares during the period. Hedge funds and other institutional investors own 99.92% of the company’s stock.
Several analysts have commented on the stock. Royal Bank Of Canada restated a “buy” rating and set a $26.00 target price on shares of K2M Group Holdings in a report on Thursday, July 20th. BidaskClub upgraded shares of K2M Group Holdings from a “hold” rating to a “buy” rating in a report on Wednesday, July 19th. Cowen and Company restated a “buy” rating and set a $26.00 target price on shares of K2M Group Holdings in a report on Wednesday, July 19th. Needham & Company LLC restated a “buy” rating on shares of K2M Group Holdings in a report on Wednesday, August 2nd. Finally, Oppenheimer Holdings, Inc. set a $29.00 target price on shares of K2M Group Holdings and gave the stock a “buy” rating in a report on Wednesday, August 2nd. One research analyst has rated the stock with a sell rating, one has issued a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $25.00.
In related news, insider John Philip Md Kostuik sold 1,332 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $23.30, for a total value of $31,035.60. Following the completion of the transaction, the insider now directly owns 200,629 shares of the company’s stock, valued at $4,674,655.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 5.80% of the stock is currently owned by company insiders.
Shares of K2M Group Holdings, Inc. (KTWO) opened at $18.35 on Wednesday. The company has a current ratio of 3.06, a quick ratio of 1.67 and a debt-to-equity ratio of 0.29. K2M Group Holdings, Inc. has a fifty-two week low of $17.23 and a fifty-two week high of $25.99.
K2M Group Holdings (NASDAQ:KTWO) last posted its quarterly earnings data on Wednesday, November 1st. The medical device company reported ($0.20) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.19) by ($0.01). K2M Group Holdings had a negative net margin of 16.22% and a negative return on equity of 16.02%. The business had revenue of $62.65 million during the quarter, compared to analyst estimates of $62.69 million. During the same quarter last year, the business earned ($0.19) earnings per share. K2M Group Holdings’s revenue for the quarter was up 5.6% on a year-over-year basis. equities research analysts forecast that K2M Group Holdings, Inc. will post -0.86 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “K2M Group Holdings, Inc. (KTWO) Position Lifted by Gamco Investors INC. ET AL” was first posted by Week Herald and is owned by of Week Herald. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://weekherald.com/2017/11/15/k2m-group-holdings-inc-ktwo-position-lifted-by-gamco-investors-inc-et-al.html.
About K2M Group Holdings
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.